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ONCOLYTIC EFFECT OF NEWCASTLE DISEASE VIRUS ON THE MCF-7 
AND MDA-MB-231 BREAST CANCER CELL LINES 
By 
NARAYANIMEVYAPPAN 
August 2003 
Chairman: Associate Professor Fauziah Othman, Ph.D. 
Faculty: Medical and Health Sciences 
The study was conducted to find a new anti-cancer agent for the treatment of breast 
cancer. The oncolytic effect of Newcastle disease virus (NDV) on MCF-7 and MDA-
MB-231 breast cancer cell lines was investigated using various methods. The V 4-
UPM and AF2240 strains of NDV were propagated in the allantoic fluid of 11-days-
old embryonated eggs. The allantoic fluid was harvested, purified and stored at -
20°C. The haemagglutination (HA) test was conducted on the purified viruses to ' 
determine the HA titre of the V4-UPM and AF2240 strains, which were 16 384 and 
128 HA units consecutively. The microculture tetrazo1ium (MTT) assay was carried 
out to detect the cytotoxic effect of the NDV strains on breast cancer cell lines using 
monolayer and co-culture techniques to determine the ICso value. The ICso values for 
the MCF-7 treated with V4-UPM strain were 4096 and 128 HA units for the 
monolayer and co-culture, respectively, while, the MDA-MB-231 had an ICso value 
of 96 HA units for both techniques. When treated with AF2240 strain, MCF-7 
showed ICso value of 96 and 64 HA units for the monolayer and co-culture methods, 
respectively. Whereas, the ICso value for MDA-MB-231 cells was 4 HA units for 
both techniques. Further studies were done to observe the ultrastructural changes in 
the treated cells and viewed under an energy filter transmission electron microscope 
IV 
filter transmission electron microscope (EFfEM). The morphological features were 
also observed under a confocal microscope whereby the cells were stained with 
acridine orange (AO) and propidium iodide (PI). The treated cells showed apoptotic 
features such as cell shrinkage, nuclear fragmentation, chromatin condensation, 
cytoplasmic vacuolisation, cell bleb bing and formation of apoptotic bodies. 
However, control cancer cells did not show any prominent changes and intact 
nucleus and clear cytoplasm were noticed. For the identification of the presence of 
the NDV, the cells were labelled with a polyclonal antibody and anti-chicken FITC. 
The NDV was found in the cytoplasm of the MCF-7 and MDA-MB-231 cells and 
occasionally in the nucleus of the MDA-MB-231 cells at day 3 post-inoculation. The 
TdT-mediated dUTP nick-end labelling (TUNEL) assay was conducted to 
specifically label and quantify the percentage of apoptotic cells via lesion scoring 
under a fluorescence microscope. The statistical analysis using independent t-test 
revealed that the apoptotic activity of V4-UPM and AF2240 strains on the MCF-7 
and MDA-MB-231 cells are significantly different (p ::; 0.05) and the susceptibility 
of these cell lines towards the V 4-UPM and AF2240 strains are also significantly 
different (p :S 0.05). From the data obtained, the AF2240 strain was found to be 
significantly more effective, while the MDA-MB-231 cells demonstrated to be 
significantly more responsive towards the NDV strains. These findings confirmed 
that the mode of cell death induced by the NDV strains is apoptosis. This study also 
suggests that the V4-UPM and AF2240 strains of NDV can be a potential anti-cancer 
agent for the treatment of breast cancer. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk Ijazah Master Sains 
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KESAN ONKOLITIK VIRUS NEWCASTLE DISEASE TERHADAP MCF-7 
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Oleh 
NARAYANIMEYYAPPAN 
Ogos 2003 
Pengerusi: Profesor Madya Fauziah Othman, Ph.D. 
Fakulti: Perubatan dan Sains Kesihatan 
Kajian ini dijalankan untuk mencari agen anti-kanser baru bagi merawat kanser 
payudara. Kesan onkolitik virus Newcastle disease (NDV) terhadap MCF-7 dan 
MDA-MB-231 sel-sel kanser payudara telah disiasat mengggunakan pelbagai 
kaedah. Virus V4-UPM dan AF2240 NDV telah dipropagasi dalam cecair alantoid 
telur embrio berusia 11  hari. Cecair alantoid tersebut telah di kumpul, dipurifikasi 
dan disimpan dalam -20°C. Ujian heamagglutinasi (HA) telah dilakukan terhadap 
virus yang dipurifikasi untuk menentukan titer HA bagi virus V 4-UPM dan AF2240, 
iaitu 16 384 HA unit untuk V4-UPM dan 128 HA unit untuk AF2240. Ujian 
microculture tetrazolium (MIT) telah dijalankan untuk mengenalpasti kesan 
sitotoksik virus NDV terhadap sel-sel kanser payudara menggunakan 2 kaedah, iaitu 
kaedah 'monolayer' dan 'co-culture' bagi menentukan nilai ICso. Nilai-nilai ICso sel 
MCF -7 yang dirawat dengan virus V 4-UPM ialah 4096 HA unit untuk kaedah 
'monolayer' dan 128 HA unit untuk kaedah 'co-culture'. Sementara, sel MDA-MB-
231 mempunyai ICso bemilai 96 HA unit untuk kedua-dua kaedah. Apabila dirawat 
dengan virus AF2240, sel MCF-7 menunjukkan ICso bemilai 96 HA unit untuk 
kaedah 'monolayer' dan 64 HA unit untuk kaedah 'co-culture'. Nilai ICso untuk sel 
MDA-MB-231 pula ialah 4 HA unit untuk kedua-dua kaedah. Kajian selanjutnya 
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telah dijalankan untuk meneliti perubahan ultrastruktur sel-sel yang dirawat dengan 
menggunakan rnikroskop elektron pancaran penuras tenaga (EFTEM). Ciri-ciri 
morfologi juga dikaji di bawah rnikroskop konfokal dimana sel-sel diwarnakan 
dengan acridine orange (AO) dan propidium iodide (PI). Sel-sel yang dirawat 
menunjukkan ciri-ciri apoptotik seperti pengecutan sel, fragmentasi nukleus, 
pengkondensasian kromatin, pembentukan vakul-vakul sitoplasma, 'blebbing' sel 
dan pembentukan jasad-jasad apoptotik Walau bagaimanapun, sel-sel kanser 
kawalan tidak mempunyai sebarang perubahan yang ketara dan menunjukkan 
nukleus dan sitoplasma yang sempuma. Untuk mengenalpasti kehadiran NDV, sel­
sel dilabel dengan antibody 'anti-chicken' poliklonal dan 'anti-chicken FITC'. NDV 
telah dikesan di dalam sitoplasma sel-sel MCF-7 dan MDA-MB-231 dan kadang­
kadang didapati di dalam nukleus sel MDA-MB-231 pada hari ketiga inokulasi. 
Ujian 'TdT-mediated dUTP nick-end labelling' (TUNEL) telah dilakukan untuk 
melabel secara spesifik dan mengkuantifikasi peratus sel-sel apoptotik melalui 
kaedah skor lesi dengan menggunakan rnikroskopi floresens. Analisis statistik 
menggunakan 'independent t-test' menunjukkan bahawa aktiviti apoptotik virus V 4-
UPM dan AF2240 terhadap sel-sel MCF-7 dan MDA-MB-231 adalah berbeza secara 
signifikan (p ::s 0.05) dan sensitiviti sel-sel ini terhadap virus V4-UPM dan AF2240 
adalah juga berbeza secara signifikan (p ::s 0.05). Dari maklumat yang diperolehi, 
kesan virus AF2240 didapati lebih secara signifikan, sementara, sel MDA-MB-231 
menunjukkan bahawa ia lebih reaktif terhadap virus NDV. Penemuan ini 
mengesahkan bahawa mod kematian sel yang dirangsang oleh virus NDV ialah 
apoptosis. Kajian ini juga mencadangkan bahawa virus V 4-UPM dan AF2240 NDV 
boleh menjadi agen anti-kanser yang berpotensi untuk rawatan kanser payudara. 
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CHAPTER! 
INTRODUCTION 
Cancer is a group of diseases that cause cells in the body to change and grow out of 
control. Most types of cancer cells form a lump or mass called a tumour, and are 
named after the part of the body where the tumour first starts. Breast cancer begins in 
breast tissue, which is made up of glands for milk production, called lobules, and the 
ducts that connect lobules to the nipples. The remainder of the breast is made up of 
fatty, connective, and lymphatic tissue. Most types of tumours that form in the breast 
are benign. Benign breast tumours are abnormal growths, but they do not grow and 
spread like cancer, and are not life-threatening. Some breast tumours are cancerous, 
but are called in situ, because they have not spread beyond the area where they 
began. In situ breast cancers are confined within the ducts or lobules of the breast. 
The majority of these tumours will not progress to become an invasive tumour, and 
at this early stage, nearly all of these cancers can be cured. However other cancerous 
breast tumours are invasive, or infiltrating. These cancers start in the ducts or lobules 
of the breast but have broken through the duct or gland walls to invade the 
surrounding fatty tissue of the breast. The seriousness of invasive breast cancer is 
strongly influenced by the stage of the disease, or how far the cancer has spread 
when it is first diagnosed. 
Breast cancer is the most common cancer among woman, and is the main cause of 
cancer death among women in Malaysia The rate of the cancer incidence differs 
between different countries. The highest rate is in America and Europe while the 
2 
lowest rate is in Asia and Africa The estimated breast cancer incidence in Malaysia 
is about 35 for every 1 00 000 population in the year 2000 (yip, 2002). The incidence 
of breast cancer has been rising for the past two decades, while mortality has 
remained relatively stable since the 1 950s. In 2001 ,  approximately 192 200 new 
cases of invasive breast cancer were diagnosed among women in America (Thomas 
et al., 2002). 
Important risk factors for female breast cancer include early age at onset of 
menarche, late age at onset of menopause, first full-term pregnancy after age 30, a 
history of pre-menopausal breast cancer or of benign proliferative breast disease. 
Obesity, nulliparity, and urban residence also have been shown to be associated with 
increased risk of breast cancer (Thomas et aI., 2002). 
Scientists and research groups are working for the improvement for the treatment of 
breast cancer. The currently available treatments for breast cancer patients are 
chemotherapy, hormone therapy and radiotherapy, but they are not always effective 
and often have unpleasant side effects. The efficacy of the treatment depends on the 
type and the stage of the cancer. Some research is directed to find better ways to use 
the available drugs, while other research focused on development of new drugs for 
the treatment of breast cancer that includes the development of anti-cancer from 
natural products, cancer vaccines and gene therapy. With the development of 
advanced molecular biology techniques, viruses of animal origin have been tested for 
virus therapy of human cancers. The Newcastle disease virus (NDV) has been shown 
to exhibit outstanding anti-cancer effect on various cancer cells. 
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NOV is a paramyxovirus that causes Newcastle disease in a wide variety of birds and 
chickens. This fatal disease is characterised by inflammation of respiratory tract and 
or either brain or the gastrointestinal tract. NDV can also infect humans, but it is 
generally not very virulent, causing only mild-fiu-like symptoms or conjunctivitis or 
laryngitis. The perception that NOV can replicate up to 10 000 times better in human 
cancer cells than in most normal human cells has prompted much interest in this 
virus as a potential anti-cancer agent. Numerous in-vitro and in-vivo studies have 
been carried out on the oncolytic activity of NDV, which includes clinical studies in 
the United States, Germany and Hungary. NDV strains that were used in most of 
these studies are the 73-T, Ulster, MTH-68, Italien, Hickman and PV701 (Cassel and 
Garret, 1965; Lorence et a!., 1988; Schild et a!., 1988; Bohle et ai., 1990; Reichard et 
al., 1992; Csatary et al., 1993; Lorence et aI., 1994a; Lorence et al., 1994b; Plaksin 
et ai., 1994; Sinkovics and Hovarth, 1995; Csatary et aI., 1999; Anonymous, 2001; 
Fabian et ai., 2001; Phuangsab et a!., 2001; Schirrmacher et a!., 2001; Washburn and 
Schirrmacher, 2002). 
In this study, the oncolytic effect of a local strain ofNDV, which is the AF2240 and 
two modified vaccine strains, namely V4-UPM and S strains were tested on the 
breast cancer cell lines in-vitro. These strains of NDV have been characterised by 
Universiti Putra Malaysia (UPM) researchers. However, no studies have been carried 
out to investigate the anti-cancer effect of the virus for cancer treatment in Malaysia 
According to current literature review, the NDV -based anti-cancer therapies have 
been reported to be of benefit (Reichard et a!., 1992; Csatary et aI., 1993; Lorence et 
a!., 1994a; Lorence et a!., 1994b; Plaksin et a!., 1994; Sinkovics and Hovarth, 1995). 
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The NDV demonstrated to be a potential anti-cancer agent and it could be the choice 
of treatment for cancer patients in Malaysia in the future. 
A new perspective on anti-cancer therapeutic efficacy and the possibility of new 
targets for anti-cancer agent is offered by the principle that cytotoxic drugs operate 
primarily by causing apoptosis in tumour cells and participate in tumour regression. 
Apoptosis (from the Greek apo: off and ptosis: a falling off or dropping off) is 
defined as 'a single deletion of scattered cells by fragmentation into membrane­
bound particles which are phagocytosed by other cells, believed to be due to 
programmed cell death (Boise et aI., 1995). With the realization of the importance of 
this process, a variety of techniques have been used to study apoptosis. The process 
of apoptosis can be used to evaluate drug toxicity and therapeutic efficacy in the 
studies involving NDV, as a new approach for cancer treatments. 
The general objective of this study is to: 
Identify a new anti-cancer agent for the treatment of breast cancer. 
The specific objectives are to: 
1)  determine the ICso value of the breast cancer cell lines inoculated with NDV 
strains using the microculture tetrazolium (MIT) assay to evaluate the cytotoxic 
effect, 
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2) observe the ultrastructural changes of the cells inoculated with NDV strains, 
under energy filter transmission electron microscope (EFTEM), 
3) observe the morphological changes of the cells stained with a combination of 
acridine orange and propidium iodide stains under confocal microscope, 
4) detect the presence and location of the VIrus by immunolabelling with a 
polyclonal antibody and goat-anti-chicken FITC, 
5) detect DNA strand breaks in apoptotic cells using TUNEL labelling assay 
(Dead End Fluorometric TUNEL System), and 
6) quantify the percentage of apoptotic cells by conducting lesion scoring under 
fluorescence microscope and followed by statistical analysis. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Breast Cancer 
Breast cancer is the most frequently diagnosed cancer in women. The incidence of 
breast cancer has been increasing constantly over the past several decades. The 
lifetime risk of developing breast cancer is 12.2%, or 1 in 8 women. The lifetime risk 
of dying of breast cancer is 3.6%, or 1 in 28 women (Doff, 1998). The incidence of 
breast cancer is rare below the age of 30 but increases beyond the age of 50, as it 
continues to rise but more slowly compared to premenopausal women (Taylor et ai., 
2000). 
2.2 Etiology and Risk Factors 
About a third of women with breast cancer relate to a family history on one or more 
first-degree relatives with breast cancer and of these 4 to 9% have hereditary breast 
cancer. Hereditary breast cancer is, however, believed to be responsible for up to 
25% of breast malignancies that occur prior to age 30 (DOff, 1998). 
Factors leading to an increased risk of breast cancer include mutations in the breast 
cancer susceptibility gene BRCA-l and BRCA-2. Mutation in these genes causes 
majority of hereditary breast cancers. However, hereditary breast cancer account for 
only 5% to 10% of all breast cancers (Taylor et ai. , 2000). 
